Day: June 3, 2024

KP Tissue Reminds Shareholders to Vote in Advance of Deadline for 2024 Annual Meeting of Shareholders

MISSISSAUGA, Ontario, June 03, 2024 (GLOBE NEWSWIRE) — KP Tissue Inc. (“KPT” or the “Company”) (TSX:KPT) would like to remind shareholders to vote in connection with the Company’s upcoming annual meeting of shareholders (the “Meeting”), to be held on Tuesday, June 11, 2024 at 2:00 PM ET. Shareholders are advised to vote their shares well in advance of the proxy voting deadline of Friday, June 7, 2024 at 2:00 PM ET. YOUR VOTE IS IMPORTANT NO MATTER HOW MANY SHARES YOU HOLD.PLEASE VOTE YOUR SHARES TODAY. THE BOARD OF DIRECTORS RECOMMENDS THAT SHAREHOLDERS VOTE FOR ALL MEETING RESOLUTIONS. Shareholders are encouraged to read the materials relating to the Meeting, available on the Company’s website www.kptissueinc.com as well as under KPT’s profile at www.sedarplus.ca. In the interest of time, shareholders may vote online or by telephone...

Continue reading

Beyond, Inc. to Participate in Upcoming Investor Conferences

MIDVALE, Utah, June 03, 2024 (GLOBE NEWSWIRE) — Beyond, Inc. (NYSE:BYON), owner of Overstock, Bed Bath & Beyond, Zulily, and other online retail brands designed to unlock your home’s potential, today announced that the company will be participating in the following investor events: UBS Consumer Insights Day, with virtual participation and a fireside chat on June 13, 2024 at 11:30 a.m. ET. This fireside chat will be webcast to UBS clients only. Jefferies Consumer Conference in Nantucket on June 17-18, 2024. This conference is not being webcast. About Beyond Beyond, Inc. (NYSE:BYON), based in Midvale, Utah, is an ecommerce expert with a singular focus: connecting consumers with products and services that unlock their homes’ potential. The Company owns Overstock, Bed Bath & Beyond, Baby & Beyond, Zulily, and other...

Continue reading

LIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schellens as Chief Medical Officer

Jan Schellens, M.D., Ph.D., as Chief Medical Officer (CMO) Lixte Biotechnology Holdings, Inc. PASADENA, Calif., June 03, 2024 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical-stage pharmaceutical company developing a new class of cancer therapy to enhance chemotherapy and immunotherapy, today announced the appointment of Jan Schellens, M.D., Ph.D., as Chief Medical Officer (CMO). Dr. Schellens brings to LIXTE more than 25 years of clinical experience as a medical oncologist, pharmacologist and clinical pharmacologist, including more than two decades developing and bringing new drugs to market. He assumes the CMO role at LIXTE effective August 1, 2024, succeeding James S. Miser, M.D., who is leaving the Company after serving in this capacity since 2020. “Dr....

Continue reading

electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

ROCKAWAY, N.J., June 03, 2024 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR) (“electroCore” or the “Company”), a commercial-stage bioelectronic medicine and wellness company, today announced that it has agreed to issue and sell to an institutional accredited investor an aggregate of 225,000 registered pre-funded warrants to purchase shares of common stock and unregistered warrants to purchase up to an aggregate of 112,500 shares of common stock. The pre-funded warrants were sold at a purchase price of $6.43 minus $0.001 per pre-funded warrant, and are exercisable immediately at an exercise price of $0.001 per share. Each share of common stock is being sold together with one-half of one warrant at a combined effective offering price of $6.4925 per share and related warrant. The warrants will be immediately exercisable after...

Continue reading

Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform

The integrated aPROMISE solution to be demonstrated on Siemens Healthineers’ syngo.via platform at the SNMMI annual meeting BEDFORD, Mass., June 03, 2024 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced that aPROMISE, its AI-enabled FDA-cleared medical device software, is now available on the syngo.via platform, from Siemens Healthineers, one of the leading workstation systems. Siemens Healthineers will be demonstrating the integrated solution at the upcoming annual Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in Toronto June 8-11, 2024. aPROMISE is a deep learning-enabled, FDA-cleared medical device software that...

Continue reading

FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device

Clinical studies in anxiety and insomnia expected to commence in the third quarter of 2024 HOUSTON, TX, June 03, 2024 (GLOBE NEWSWIRE) — Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) announces that the U.S. Food and Drug Administration (FDA) has provided feedback and reached consensus on the design for its planned clinical studies in anxiety and insomnia for its new Gen-3 HALO Clarity™ (“HALO”), a non-invasive, Deep Intracranial Frequency Stimulation (DIFS™) headset device designed to address the global mental health epidemic. After the studies are completed and evaluated, Nexalin plans to submit a De Novo request application for the HALO to the FDA. The De Novo request provides a marketing pathway to classify new novel medical devices. The initial pilot and pivotal studies for anxiety...

Continue reading

Safety Shot, World’s First Beverage to Reduce Blood Alcohol Content, Announces Launch of New 4-Ounce Bottles

Innovative Formula To Be Available in Portable Format for Enhanced Accessibility and Convenience JUPITER, FL, June 03, 2024 (GLOBE NEWSWIRE) — Safety Shot, Inc. (Nasdaq: SHOT) (the “Company), announced today the launch of its revolutionary formula in new, convenient 4-ounce bottles. Designed for easy on-the-go use, this new format ensures that customers can enjoy the benefits of Safety Shot’s groundbreaking formula anytime, anywhere. Safety Shot is a first of its kind functional beverage crafted with Essential B vitamins, antioxidants, electrolytes, and nootropics designed to boost mental clarity, energy and overall mood. Disrupting the industry and creating a category of one, Safety Shot is the world’s first beverage to reduce blood alcohol content by supporting its metabolism in as little as 30 minutes. The 4-ounce bottles...

Continue reading

Paradies Lagardère Introduces ARHT Holograms in New Retail Experience at Toronto Pearson International Airport

TORONTO, June 03, 2024 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT” or “the Company”) (TSXV: ART), (OTCQB: ARHTF) the global leader in the development, production and distribution of high-quality, low latency hologram and digital content, is excited to announce that ARHT CAPSULE will be featured in Paradies Lagardère’s newest retail engagement, The Goods Express@YYZ, at Toronto Pearson International Airport. This innovative, checkout-free retail experience also includes Amazon’s Just Walk Out technology, showcasing the seamless integration of advanced retail and digital technologies. The location’s unveiling marks the first in-store use of the ARHT CAPSULE in a Canadian airport. This innovative technology was introduced to Toronto Pearson travelers during the holidays with a seasonal promotion and will...

Continue reading

TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement and Receives an Extension on Compliance with Nasdaq Filing Requirement

BEIJING, June 03, 2024 (GLOBE NEWSWIRE) — TIAN RUIXIANG Holdings Ltd (Nasdaq: TIRX) (the “Company”), a China-based insurance broker conducting business through its variable interest entity in China, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) on May 29, 2024, informing the Company that it has regained compliance with Nasdaq’s minimum bid price requirement under Listing Rule 5550(a)(2). According to the Notification Letter, as of May 28, 2024, the Company has maintained a closing bid price of $1.00 per share or greater for ten consecutive business days. In addition, the Company received a letter from Nasdaq on May 29, 2024 (the “Extension Notice”), granting the Company an extension until August 15,...

Continue reading

Cyber Security Market is expected to Grow from USD 168.04 Billion 2023 to reach USD 452.08 Billion in 2031

Westford,USA, June 03, 2024 (GLOBE NEWSWIRE) — Cyber security refers to the security of digital platforms and digital assets. The rapidly evolving cyber threat landscape, high incidence of data breaches and cyberattacks, and imposition of strict data privacy and security regulations are key factors that are promoting the demand for better cyber security around the world. Remote work and bring your own device (BYOD) are also key trends that have bolstered the importance of advanced cyber security measures around the world. The global cyber security market is segmented into solution type, deployment mode, organization size, security type, vertical, and region. Download a detailed overview: https://www.skyquestt.com/sample-request/cyber-security-market IAM Remains Imperative for Cyber Security Identity and access management (IAM)...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.